Skip to main content
Premium Trial:

Request an Annual Quote

Sengenics to Use OGT's Protein Array Platform for Cancer Biomarker Discovery, Clinical Trials Service

Premium

Sengenics said this week that it will launch a cancer biomarker discovery and clinical trial immunoresponse monitoring service based on Oxford Gene Technology's functional protein array platform.

Sengenics, based in Kuala Lumpur, Malaysia, said that it will launch the service in the second quarter from a new protein array facility that has been custom built to run the OGT arrays.

Sengenics had already been offering protein array-based biomarker discovery services through OGT for a number of years. A company spokesperson said that Sengenics has built a new facility that is set to open in April and designed to run the protein array technology. "This will be the first facility in the world outside Oxford that is capable of running this platform," the spokesperson said.

In a statement, John Anson, executive vice president of R&D at OGT, noted that "enabling Sengenics, our strategic partner in Asia, to provide biomarker discovery services based on our proprietary protein array platform in their own facility" would help OGT better serve the Asian market.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.